← All stocks

GYRE THERAPEUTICS, INC.

GYRE Scheduled selling only

CIK 0001124105 #2796 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$952.87K

$82.93K on a plan · $869.95K straight out of an exercise

Sold at will

$0.00

0 of 18 sales

Net

−$952.87K

$0.00 against sales at will

By person

4 insiders · 18 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ye Weiguo

Chief Operating Officer

—

$869.95K (16) scheduled

−$869.95K

700,000

0.6277%

$4.45M

—

Luo Ying

Chief Executive Officer

—

$82.93K (2) scheduled

−$82.93K

2,565,226

2.30%

$16.29M

−0.4%

Ma Songjiang

President

—

2,806,084

2.52%

$17.82M

−4.6%

Eastling Thomas Wilson

Chief Financial Officer

—

15,000

0.0135%

$95.25K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 24

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 16

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 137,414

History held since 12 Jul 2017